Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market
Holding ATHE?
Track your performance easily

Alterity Therapeutics (ATHE) Financial Statements

247 Followers

Alterity Therapeutics Financial Overview

Alterity Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.06; its P/E ratio is -0.58; Alterity Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Dec 22Jun 22Dec 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 12.64MAU$ 15.77MAU$ 25.34MAU$ 34.81MAU$ 37.00M
Total AssetsAU$ 19.22MAU$ 27.32MAU$ 33.38MAU$ 41.36MAU$ 44.93M
Total DebtAU$ 159.04KAU$ 210.38KAU$ 0.00AU$ 117.49KAU$ 41.89K
Net DebtAU$ -12.48MAU$ -15.56MAU$ -25.34MAU$ -34.69MAU$ -36.96M
Total LiabilitiesAU$ 5.43MAU$ 4.50MAU$ 5.28MAU$ 5.89MAU$ 3.80M
Stockholders EquityAU$ 13.80MAU$ 22.81MAU$ 28.10MAU$ 35.47MAU$ 41.13M
Cash Flow-
Free Cash Flow--AU$ -5.16MAU$ -72.42KAU$ -3.78M
Operating Cash Flow-----
Investing Cash Flow--AU$ -4.88KAU$ -89.15KAU$ -2.56K
Financing Cash Flow--AU$ -108.90KAU$ -285.44KAU$ -268.97K
Currency in AUD

Alterity Therapeutics Earnings and Revenue History

Alterity Therapeutics Debt to Assets

Alterity Therapeutics Cash Flow

Alterity Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis